Bruker Stock Fundamentals
| BRKR Stock | USD 58.90 1.83 3.21% |
Bruker fundamentals help investors to digest information that contributes to Bruker's financial success or failures. It also enables traders to predict the movement of Bruker Stock. The fundamental analysis module provides a way to measure Bruker's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bruker stock.
At this time, Bruker's Total Other Income Expense Net is relatively stable compared to the past year. As of 11/26/2024, Depreciation And Amortization is likely to grow to about 120.6 M, while Cost Of Revenue is likely to drop slightly above 737.2 M. Bruker | Select Account or Indicator |
Bruker Company Operating Margin Analysis
Bruker's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Bruker Operating Margin | 0.10 % |
Most of Bruker's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bruker is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Bruker Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Bruker has an Operating Margin of 0.1%. This is 100.29% lower than that of the Life Sciences Tools & Services sector and 100.25% lower than that of the Health Care industry. The operating margin for all United States stocks is 101.81% lower than that of the firm.
Bruker Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bruker's current stock value. Our valuation model uses many indicators to compare Bruker value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bruker competition to find correlations between indicators driving Bruker's intrinsic value. More Info.Bruker is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.24 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bruker is roughly 4.08 . At this time, Bruker's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Bruker by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Bruker Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bruker's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bruker could also be used in its relative valuation, which is a method of valuing Bruker by comparing valuation metrics of similar companies.Bruker is currently under evaluation in operating margin category among its peers.
Bruker ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bruker's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bruker's managers, analysts, and investors.Environmental | Governance | Social |
Bruker Fundamentals
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0483 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 11.2 B | ||||
| Shares Outstanding | 151.6 M | ||||
| Shares Owned By Insiders | 31.91 % | ||||
| Shares Owned By Institutions | 79.71 % | ||||
| Number Of Shares Shorted | 3.81 M | ||||
| Price To Earning | 67.10 X | ||||
| Price To Book | 4.94 X | ||||
| Price To Sales | 2.75 X | ||||
| Revenue | 2.96 B | ||||
| Gross Profit | 1.31 B | ||||
| EBITDA | 599 M | ||||
| Net Income | 427.2 M | ||||
| Cash And Equivalents | 733.6 M | ||||
| Cash Per Share | 4.95 X | ||||
| Total Debt | 1.38 B | ||||
| Debt To Equity | 1.20 % | ||||
| Current Ratio | 2.55 X | ||||
| Book Value Per Share | 11.92 X | ||||
| Cash Flow From Operations | 350.1 M | ||||
| Short Ratio | 3.34 X | ||||
| Earnings Per Share | 2.07 X | ||||
| Price To Earnings To Growth | 3.64 X | ||||
| Target Price | 74.74 | ||||
| Number Of Employees | 9.71 K | ||||
| Beta | 1.2 | ||||
| Market Capitalization | 8.93 B | ||||
| Total Asset | 4.25 B | ||||
| Retained Earnings | 2.32 B | ||||
| Working Capital | 962.1 M | ||||
| Current Asset | 1.23 B | ||||
| Current Liabilities | 554.6 M | ||||
| Annual Yield | 0 % | ||||
| Five Year Return | 0.36 % | ||||
| Net Asset | 4.25 B | ||||
| Last Dividend Paid | 0.2 |
About Bruker Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bruker's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bruker using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bruker based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 400 M | 420 M | |
| Total Revenue | 3 B | 3.1 B | |
| Cost Of Revenue | 1.5 B | 737.2 M | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.25 | 0.26 | |
| Research And Ddevelopement To Revenue | 0.10 | 0.14 | |
| Capex To Revenue | 0.04 | 0.05 | |
| Revenue Per Share | 20.25 | 21.26 | |
| Ebit Per Revenue | 0.15 | 0.15 |
Pair Trading with Bruker
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.Moving together with Bruker Stock
Moving against Bruker Stock
| 0.8 | EXEL | Exelixis | PairCorr |
| 0.75 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.56 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.45 | KTTAW | Pasithea Therapeutics | PairCorr |
The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.
The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.